Enyuan Shang

1.6k total citations
27 papers, 1.2k citations indexed

About

Enyuan Shang is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Enyuan Shang has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in Enyuan Shang's work include Cancer, Hypoxia, and Metabolism (9 papers), Glioma Diagnosis and Treatment (6 papers) and Protein Degradation and Inhibitors (6 papers). Enyuan Shang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (9 papers), Glioma Diagnosis and Treatment (6 papers) and Protein Degradation and Inhibitors (6 papers). Enyuan Shang collaborates with scholars based in United States, Germany and China. Enyuan Shang's co-authors include Debra J. Wolgemuth, Xiangyuan Wang, Duancheng Wen, Markus D. Siegelin, Georg Karpel‐Massler, Trang Nguyen, Helen Nickerson, David A. Greenberg, Mike‐Andrew Westhoff and William S. Blaner and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Enyuan Shang

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enyuan Shang United States 17 921 201 190 118 112 27 1.2k
Kyungsoo Ha United States 16 873 0.9× 88 0.4× 130 0.7× 104 0.9× 133 1.2× 31 1.1k
Ivana Magnani Italy 20 800 0.9× 183 0.9× 184 1.0× 177 1.5× 131 1.2× 43 1.2k
Rebecca J. Burgess United States 14 903 1.0× 132 0.7× 83 0.4× 100 0.8× 163 1.5× 18 1.3k
Lisa Pike United States 11 730 0.8× 302 1.5× 184 1.0× 57 0.5× 17 0.2× 12 1.1k
Christine R. Klaus Germany 15 1.6k 1.8× 122 0.6× 94 0.5× 51 0.4× 252 2.3× 35 1.9k
Lucia Cappabianca Italy 19 570 0.6× 282 1.4× 83 0.4× 31 0.3× 43 0.4× 45 944
Roberta Fiume Italy 28 1.1k 1.2× 102 0.5× 102 0.5× 119 1.0× 160 1.4× 54 1.4k
Gilda Raguénez France 18 614 0.7× 150 0.7× 114 0.6× 40 0.3× 56 0.5× 29 1.0k
Dwight M. Morrow United States 14 950 1.0× 142 0.7× 120 0.6× 36 0.3× 101 0.9× 33 1.3k

Countries citing papers authored by Enyuan Shang

Since Specialization
Citations

This map shows the geographic impact of Enyuan Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enyuan Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enyuan Shang more than expected).

Fields of papers citing papers by Enyuan Shang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enyuan Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enyuan Shang. The network helps show where Enyuan Shang may publish in the future.

Co-authorship network of co-authors of Enyuan Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Enyuan Shang. A scholar is included among the top collaborators of Enyuan Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enyuan Shang. Enyuan Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nguyen, Trang, Consuelo Torrini, Enyuan Shang, et al.. (2024). OGDH and Bcl-xL loss causes synthetic lethality in glioblastoma. JCI Insight. 9(8). 3 indexed citations
2.
Seigel, Gail M., Onyekwere Onwumere, Moira Sauane, et al.. (2024). ALYREF/THOC4 expression and cell growth modulation in retinoblastoma. Pathology - Research and Practice. 260. 155392–155392. 1 indexed citations
3.
Shang, Enyuan, Trang Nguyen, Mike‐Andrew Westhoff, Georg Karpel‐Massler, & Markus D. Siegelin. (2023). Targeting cellular respiration as a therapeutic strategy in glioblastoma. Oncotarget. 14(1). 419–425. 7 indexed citations
4.
Nguyen, Trang, Enyuan Shang, Mike‐Andrew Westhoff, Georg Karpel‐Massler, & Markus D. Siegelin. (2022). Therapeutic Drug-Induced Metabolic Reprogramming in Glioblastoma. Cells. 11(19). 2956–2956. 21 indexed citations
5.
Nguyen, Trang, Enyuan Shang, Mike‐Andrew Westhoff, Georg Karpel‐Massler, & Markus D. Siegelin. (2022). Methodological Approaches for Assessing Metabolomic Changes in Glioblastomas. Methods in molecular biology. 2445. 305–328. 2 indexed citations
6.
Nguyen, Trang, Enyuan Shang, Chang Shu, et al.. (2021). Aurora kinase A inhibition reverses the Warburg effect and elicits unique metabolic vulnerabilities in glioblastoma. Nature Communications. 12(1). 5203–5203. 76 indexed citations
7.
Nguyen, Trang, Yiru Zhang, Enyuan Shang, et al.. (2020). HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models. Journal of Clinical Investigation. 130(7). 3699–3716. 140 indexed citations
8.
Wang, Xiangyuan, et al.. (2020). Cyclin A2 is essential for mouse gonocyte maturation. Cell Cycle. 19(13). 1654–1664. 8 indexed citations
9.
Gharbaran, Rajendra, et al.. (2020). Luteolin Induces Cytotoxicity in Mix Cellularity Classical Hodgkin's LymphomaviaCaspase Activated-cell Death. Anticancer Research. 40(9). 4907–4912. 13 indexed citations
10.
Zhang, Yiru, Trang Nguyen, Enyuan Shang, et al.. (2019). MET Inhibition Elicits PGC1α-Dependent Metabolic Reprogramming in Glioblastoma. Cancer Research. 80(1). 30–43. 44 indexed citations
11.
Karpel‐Massler, Georg, Trang Nguyen, Enyuan Shang, & Markus D. Siegelin. (2019). Novel IDH1-Targeted Glioma Therapies. CNS Drugs. 33(12). 1155–1166. 58 indexed citations
12.
Nguyen, Trang, Chiaki Tsuge Ishida, Enyuan Shang, et al.. (2019). Activation of LXR β inhibits tumor respiration and is synthetically lethal with Bcl‐ xL inhibition. EMBO Molecular Medicine. 11(10). e10769–e10769. 43 indexed citations
13.
Shang, Enyuan, Yiru Zhang, Chang Shu, et al.. (2018). Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems. Scientific Reports. 8(1). 15383–15383. 15 indexed citations
14.
Velı́šek, Libor, Enyuan Shang, Jana Velı́šková, et al.. (2011). GABAergic Neuron Deficit As An Idiopathic Generalized Epilepsy Mechanism: The Role Of BRD2 Haploinsufficiency In Juvenile Myoclonic Epilepsy. PLoS ONE. 6(8). e23656–e23656. 59 indexed citations
15.
Shang, Enyuan, et al.. (2011). The bromodomain-containing gene BRD2 is regulated at transcription, splicing, and translation levels. Journal of Cellular Biochemistry. 112(10). 2784–2793. 24 indexed citations
16.
Shang, Enyuan, Xiangyuan Wang, Duancheng Wen, David A. Greenberg, & Debra J. Wolgemuth. (2009). Double bromodomain‐containing gene Brd2 is essential for embryonic development in mouse. Developmental Dynamics. 238(4). 908–917. 124 indexed citations
17.
Shang, Enyuan, Helen Nickerson, Duancheng Wen, Xiangyuan Wang, & Debra J. Wolgemuth. (2007). The first bromodomain of Brdt, a testis-specific member of the BET sub-family of double-bromodomain-containing proteins, is essential for male germ cell differentiation. Development. 134(19). 3507–3515. 203 indexed citations
18.
Shang, Enyuan, Thomas E. Crowley, Xiang Wang, et al.. (2004). Identification of unique, differentiation stage-specific patterns of expression of the bromodomain-containing genes Brd2, Brd3, Brd4, and Brdt in the mouse testis. Gene Expression Patterns. 4(5). 513–519. 93 indexed citations
19.
20.
Mertz, James R., et al.. (1997). Identification and Characterization of a Stereospecific Human Enzyme That Catalyzes 9-cis-Retinol Oxidation. Journal of Biological Chemistry. 272(18). 11744–11749. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyungsoo Ha Breakdown of academic impact, for papers by Ivana Magnani Breakdown of academic impact, for papers by Rebecca J. Burgess Breakdown of academic impact, for papers by Lisa Pike Breakdown of academic impact, for papers by Christine R. Klaus Breakdown of academic impact, for papers by Lucia Cappabianca Breakdown of academic impact, for papers by Roberta Fiume Breakdown of academic impact, for papers by Gilda Raguénez Breakdown of academic impact, for papers by Dwight M. Morrow
Rankless by CCL
2026